Roots Analysis

Roots Analysis provide business research and consulting in the pharmaceutical industry. Focussed on providing an informed and impartial view on key issues facing the industry, our research is primarily driven by an in-depth analysis covering the following parameters:

•Technology evolution
•Research and development
•Existing market landscape
•Future Commercial potential
•Regulatory concerns
•Regional growth drivers
•Risks and opportunities

Roots Analysis

List of reports from Roots Analysis

< prev 1    3  
CD19 Therapeutics Market, 2016 - 2030
3/31/2016 | published by: Roots Analysis
... an immune response. Immunotherapies exploit the body's innate potential to specifically target a particular molecular antigen and mount an efficient immune response against the cells bearing the diseased signature. Currently, four major types of immunotherapies ...  |  read more...
USD 2,199
Fc Protein and Glycoengineered Antibodies Market (2nd Edition), 2016 - 2026
3/31/2016 | published by: Roots Analysis
... The Y-arm of the antibody is known as Fab, comprising a constant and a variable domain from each light and heavy chain. The variable domain (Fv) within the Fab region is responsible for target specificity ...  |  read more...
USD 2,199
HPAPIs and Cytotoxic Drugs Manufacturing Market (2nd Edition), 2016 - 2026
3/9/2016 | published by: Roots Analysis
... the key focus of researchers and manufacturers worldwide. HPAPIs, which include cytotoxic APIs, are drug substances that are formulated to manufacture high potency drug products. Cytotoxic drugs are a category of highly potent drug products ...  |  read more...
USD 2,199
Speciality CROs Market, 2016-2025
2/11/2016 | published by: Roots Analysis
... overcome the shortcomings of full service / traditional CROs. Often, these full service providers offer a wider portfolio of services but fail to align their efforts to meet the requirements of sponsors, primarily the smaller ...  |  read more...
USD 2,199
Peptide Therapeutics in Metabolic Disorders, 2016 - 2025
2/8/2016 | published by: Roots Analysis
... smaller in size and can be easily synthesized, optimized and evaluated as viable therapeutic solutions for a number of diseases. These highly favourable and intrinsic characteristics of peptides have caused an evident shift in the ...  |  read more...
USD 2,199
Microbiome Therapeutics Market, 2015 - 2030
1/15/2016 | published by: Roots Analysis
... is involved in various functions that are essential to lead a healthy life. Majority of the microorganisms benefit humans by supplementing them with traits that they would otherwise not possess. These include metabolism of complex ...  |  read more...
USD 2,199
Antibody Drug Conjugates Market 3rd Edition, 2015 - 2025
12/3/2015 | published by: Roots Analysis
... with respect to technology, although the individual molecules that form ADCs have been used since long. This new class of therapeutics has witnessed a strong acceptance from both big and small pharmaceutical companies as they ...  |  read more...
USD 2,199
RNAi Therapeutics Market, 2015 - 2030
12/1/2015 | published by: Roots Analysis
... involving short strands of nucleic acids. It is a regulatory process that cells utilise to silence and/or inhibit gene expression through the destruction of specific mRNA molecules. One of the major advantages of RNAi is ...  |  read more...
USD 2,199
Infusion Pumps Market 2015 - 2025
12/1/2015 | published by: Roots Analysis
... features and ergonomic design. The market has a wide array of different types of infusion pumps (volumetric, syringe, implantable, elastomeric, ambulatory and others); combined, they offer a large range of infusion volume, flow rate, occlusion ...  |  read more...
USD 2,199
Biotherapeutics: Novel Formulation and Delivery Approaches Focus on Antibodies and Proteins 2015 - 2025
11/10/2015 | published by: Roots Analysis
... treatment of chronic diseases and also result in high profit margins for the drug developers. There are several therapeutic areas for which biopharmaceuticals are being investigated; these include oncology, metabolic disorders, viral infections, genetic disorders ...  |  read more...
USD 2,199
Non-Invasive Cancer Diagnostics Market 2015-2030
10/20/2015 | published by: Roots Analysis
... satisfying the unmet market need for advanced and efficient treatment interventions, cancer prevention, early detection and management is extremely important. The high cancer mortality rate is primarily due to delay in detection of the disease. ...  |  read more...
USD 2,199
T-Cell Immunotherapy Market 2015-2030
10/13/2015 | published by: Roots Analysis
... each year. Although cancer therapeutics continues to be one of the most active areas in terms of drug development, there is still a significant unmet need. Specifically, immuno-oncology has been gradually nurtured by researchers over ...  |  read more...
USD 2,200
NASH Drugs Market 2015-2025
9/3/2015 | published by: Roots Analysis
... defined as significant steatohepatitis not caused due to alcohol, drugs, toxins, infectious agents or other identifiable exogenous causes. NASH is often accompanied with a high possibility of cirrhosis, a condition in which the liver functions ...  |  read more...
USD 2,199
ADC Contract Manufacturing Market (2nd edition), 2015-2025
8/10/2015 | published by: Roots Analysis
... be very effective and efficient in treatment of a disease. However, manufacturing such highly potent toxic molecules is accompanied with several known and unknown challenges. In-house manufacturing of ADCs is rare primarily because of the ...  |  read more...
USD 2,199
Global Biosimilars Market 2015 - 2025
7/22/2015 | published by: Roots Analysis
... are on the lookout for novel strategies that will help them attain maximum returns on investment. Derived from biological elements, biologic medications have transformed the treatment paradigm of life threatening, debilitating diseases. However, such drugs ...  |  read more...
USD 2,199
Immune Checkpoint Inhibitors Market (2nd edition), 2015-2025
7/20/2015 | published by: Roots Analysis
... orphan forms. Although oncology continues to be one of the most active areas in terms of drug development, there is still a significant unmet need. The focus of drug developers is gradually moving towards immunotherapeutics, ...  |  read more...
USD 2,199
Pharmaceutical Anti-Counterfeiting Technologies Market 2015 - 2025
7/6/2015 | published by: Roots Analysis
... primarily revolves around the health of patients rather than revenue losses in the industry. Counterfeit drugs create substantial public health hazards and cause crucial safety concerns. Falsified or substandard drugs can lead to adverse reactions ...  |  read more...
USD 2,199
Prefilled Syringes Market 2015 - 2025 3rd Edition
6/29/2015 | published by: Roots Analysis
... devices have become preferred devices for parenteral administration of drugs, mainly used for treatment of chronic conditions requiring patients to self-administer medication several times a week. The origins of prefilled syringes can be traced back ...  |  read more...
USD 2,199
3D Cell Culture Market 2015-2025
5/28/2015 | published by: Roots Analysis
... are useful for studying the basic human molecular and cell biology metabolisms. Cell culturing was first initiated in flat plastic or glass dishes as 2D cell culturing. Since then, all the tissue engineering, stem cell, ...  |  read more...
USD 2,199
Sustained Release Ocular Drug Delivery Systems, 2015 - 2025 (2nd edition)
5/25/2015 | published by: Roots Analysis
... specific ocular site. Several barriers have to be overcome for a successful ocular drug delivery. These include dilution of a drug by tears, clearance of a drug by the lymphatic system of conjunctiva and drug ...  |  read more...
USD 2,199
Blood Brain Barrier Technologies: Novel CNS Drug Delivery Approaches’
5/12/2015 | published by: Roots Analysis
... not treat the root cause. This is because of their inability to penetrate across the blood brain barrier (BBB). BBB is a highly selective permeable membrane which allows the entry of only specific molecules, across ...  |  read more...
USD 2,199
Biopharmaceutical Contract Manufacturing Market, 2015 - 2025
5/5/2015 | published by: Roots Analysis
... to serving as a cost-cutting tool, contract manufacturing provides several other advantages to biopharmaceutical companies including technical expertise, operational efficiency, regulatory support and the ability to focus on core competencies. Spanning multiple operations within the ...  |  read more...
USD 2,199
Non-Tyrosine Kinase Inhibitors in Oncology, 2015 - 2025
4/24/2015 | published by: Roots Analysis
... many pharmaceutical companies to improve these treatments as well as discover novel cancer therapies with minimum toxic effects. Targeted cancer therapy is an upcoming area gaining strong foothold in the industry and has already become ...  |  read more...
USD 2,199
Rare Diseases The Pharmaceutical Landscape and Opportunity Areas
3/23/2015 | published by: Roots Analysis
... ailments. However, there are certain diseases, termed as rare, that continue to remain untreated and neglected. Rare / orphan diseases, as the name suggests, are those diseases which are relatively infrequent in occurrence. Many orphan ...  |  read more...
USD 2,799
Gene Therapy Market, 2015 - 2025
2/25/2015 | published by: Roots Analysis
... or delete the genes causing a particular disease is known as gene therapy. Although gene therapy has not contributed significantly to the global pharmaceutical market yet, it is anticipated to grow at a fast pace ...  |  read more...
USD 2,199
< prev 1    3  
US: 800.298.5699
Int'l: +1.240.747.3093
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!